Skip to main content

Subscribe to the RheumNow podcast on your favorite podcast app to get automatic downloads of the latest content. Listen

Social Author Name
Dr. John Cush
Tweet Content
Subscribe to the RheumNow podcast on your favorite podcast app to get automatic downloads of the latest content. Listen in the car, airplane, anywhere! Rate, review and subscribe! https://t.co/3EENe1VFKl https://t.co/V0X5BAtDBq
The Late Edition (2.24.2023)

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com

Which Meds are Best for Acute Low Back Pain? Acute low back pain (LBP) is a common cause of disability. An analysis in

Social Author Name
Dr. John Cush
Tweet Content
Which Meds are Best for Acute Low Back Pain? Acute low back pain (LBP) is a common cause of disability. An analysis in the Journal of Orthopaedic Research examined which non-opioid drugs are best for treating this condition. https://t.co/StteWi87Y5 https://t.co/9CvYIqx5Cv

New Drug Formulations – For Patients or Profits? Wang et al in JAMA Network Research Letter, reviewed Medicaid expend

Social Author Name
Dr. John Cush
Tweet Content
New Drug Formulations – For Patients or Profits? Wang et al in JAMA Network Research Letter, reviewed Medicaid expenditures on ADA, noted that the introduction of the citrate-free formulation cost an extra $4.4B to Medicaid from 2014-2021. https://t.co/W1sst12GJK https://t.co/OYLkSHEQ2X

32 men w/ B27+ #AS (Rx NSAIDs, BASDAI ~5.3) underwent exercise training (10d, 60min) w/ or w/o Pre-Rx w/ whole-body cryo

Social Author Name
Dr. John Cush
Tweet Content
32 men w/ B27+ #AS (Rx NSAIDs, BASDAI ~5.3) underwent exercise training (10d, 60min) w/ or w/o Pre-Rx w/ whole-body cryotherapy (WBC). WBC had significant drops in hsCRP, sP-Selectin, sVCAM-1, neopterin & signif decreases in BASDAI, BASFI, pain intensity https://t.co/8bmjTS4VOk https://t.co/ajrD8Z7C8v
Subscribe to
×